C12Y 101/01271
Gdp-l-fucose synthase
Official title: GDP-L-fucose synthase (1.1.1.271)
C12Y101/01271 (Gdp-l-fucose synthase) appears on 18 US grants and 38 published applications in this corpus.
Search patents in C12Y- Granted patents
- 18
- Published applications
- 38
- Assignees
- 23
- Inventors
- 81
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 1 |
| 2017 | 2 | 1 |
| 2018 | 1 | 1 |
| 2019 | 0 | 3 |
| 2020 | 2 | 3 |
| 2021 | 0 | 6 |
| 2022 | 2 | 4 |
| 2023 | 3 | 3 |
| 2024 | 4 | 6 |
| 2025 | 1 | 4 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Production of milk oligosaccharides in plants18 Aug 2026US 12,709,757 B2The Regents of the University of California
- Oligosaccharide production in yeast cells expressing an ABC transporter protein15 Jul 2025US 12,359,234 B2Amyris, Inc.
- Engineered microorganisms for production of 2′fucosyllactose and l-fucose3 Sep 2024US 12,077,792 B2Korea University Research and Business Foundation
- Fucosylation-deficient cells6 Aug 2024US 12,054,751 B2Regeneron Pharmaceuticals, Inc.
- Increasing export of 2'fucosyllactose from microbial cells through the expression of a heterologous nucleic acid27 Feb 2024US 11,913,046 B2Inbiose N.V.
- Afucosylation modification11 Jun 2026US 2026/0159573 A1Genentech, Inc.
- Oligosaccharide production in yeast12 Mar 2026US 2026/0071245 A1Amyris, Inc.
- Recombinant microorganism expressing fucosyltransferase, and method of producing 2'-fucosyllactose using same13 Nov 2025US 2025/0346912 A1Samyang Corporation
- Compositions and methods for improved production of human milk oligosaccharides25 Sep 2025US 2025/0297294 A1Amyris, Inc.
- Glycosyltransferase deficient corynebacterium for the production of fucosyllactose11 Sep 2025US 2025/0283130 A1Galab Laboratories GmbH
Most cited
By later US patents
- Fucosylation-deficient cells10US 8,409,838 B2Regeneron Pharmaceuticals, Inc. · 2013
- Fucosylation-deficient cells4US 9,206,455 B2Regeneron Pharmaceuticals, Inc. · 2015
- Fucosylation-deficient cells2US 9,550,823 B2Regeneron Pharmaceuticals, Inc. · 2017
- Fucosylation-deficient cells1US 10,006,070 B2Regeneron Pharmaceuticals, Inc. · 2018
- Corynebacterium glutamicum for use in producing 2′-fucosyllactose1US 10,570,399 B2Seoul National University R&Db Foundation · 2020